Henry Schein, Inc. (HSIC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 10 | 12 | 13 | 12 | 13 | 13 | 14 | 14 |
| Operating profit | $bn | 1 | 1 | ||||||
| Net profit | $bn | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| EPS reported | $ | 3.27 | 3.43 | ||||||
| Operating cashflow per share | $ | 5.89 | 6.17 | ||||||
| Capex per share | $ | 1.15 | 1.42 | ||||||
| FCF per share | $ | 4.74 | 4.75 | ||||||
| Free cash flow | $bn | 1 | 1 | ||||||
| Net debt | $bn | 3 | 3 | ||||||
| Book value equity | $bn | 3 | 3 | ||||||
| Book value per share | $ | 26.66 | 27.60 | ||||||
| Number of shares | m | 121.72 | 114.39 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 23.28 | 25.18 | ||||||
| P/B LTM | x | 2.83 | 2.91 | ||||||
| P/S LTM | x | 0.70 | 0.68 | ||||||
| P/FCF LTM | x | 16.05 | 17.06 | ||||||
| EV/EBITDA LTM | x | 12.65 | 12.35 | ||||||
| EV/Sales LTM | x | 0.97 | 1.02 | ||||||
| Earnings Yield LTM | % | +4.30% | +3.97% | ||||||
| FCF Yield | % | +6.23% | +5.86% | ||||||
| Quality | |||||||||
| ROE | % | +12.27% | +12.37% | ||||||
| ROIC | % | +6.58% | +6.47% | ||||||
| Operating margin | % | +5.75% | +5.69% | ||||||
| Gross margin | % | +29.14% | +30.31% | ||||||
| FCF/Sales | % | +4.35% | +3.96% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +7.21% | +12.46% | ||||||
| Sales Growth YoY | % | +4.03% | +7.33% | ||||||
| Net Income Growth YoY | % | +2.05% | +3.33% | ||||||
| FCF Growth | % | -13.31% | -18.46% | ||||||
| Operating Profit Growth | % | +3.98% | +6.17% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.16 | 0.14 | ||||||
| Net Debt/EBITDA | x | 3.51 | 3.55 | ||||||
| EBIT/Net interest | x | 5.05 | 4.87 | ||||||
| Net debt/market cap | % | +37.36% | +33.85% | ||||||
| Net debt/Equity | x | 1.01 | 1.05 | ||||||
| Gross debt/equity | x | 1.14 | 1.21 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free